ECMO Patients' antibiotic levels under the microscope
NCT ID NCT02917486
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the body processes an antibiotic called piperacillin in intensive care patients who are on a life-support machine (ECMO) compared to those who are not. Researchers wanted to see if ECMO changes antibiotic levels, which could affect how well the drug fights infections. The study included 44 adults with sepsis and used blood tests to measure drug exposure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Rennes
Rennes, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Aging in place: could mobile teams keep nursing home residents out of the hospital?
- Blood markers may foretell brain fog after sepsis